Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Want to turn your skills into cash? Explore ways to monetize your skills fast and increase your income.
19,311 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
The CDC has expanded its Ebola response after the WHO declared an international public health emergency, deploying mo...
Even a $1.3 million nest egg can fall short of covering Medicare gaps, forcing tighter budgets and smarter insurance ...
Late Saturday, gunfire near the White House prompted a rapid security response. Authorities reported no injuries, whi...
A 2026 market backdrop prompts a fresh look at when to retire early. A saver chasing seven figures weighs the 4% rule...
U.S. adults now smoke at a record low, but a shift in public-health funding threatens the playbook that drove the dec...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
A high-net-worth retiree with a $2.1 million 401(K) moves to Nevada to minimize state taxes before his first RMD at 7...
Rising U.S. rates and currency shifts push many Americans to Guanacaste’s shores. Here's a practical, up-to-date budg...
Two energy infrastructure ETFs are under the lens as crude markets stay volatile. EMLP and ENFR continue payouts, but...
Investors bias portfolios by political leanings, potentially hurting gains. Experts say open dialogue across camps ca...
Insider moves always spark questions. This article unpacks EverCommerce's sells 19,200 shares, what it signals, and h...